ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

TALS Talaris Therapeutics Inc

2.72
0.00 (0.00%)
Pre Market
Last Updated: 19:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Talaris Therapeutics Inc TALS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 2.72 19:00:00
Open Price Low Price High Price Close Price Previous Close
2.72
more quote information »

Recent News

Date Time Source Heading
4/19/202415:05EDGAR2Form ARS - Annual Report to Security Holders
4/19/202415:04EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
4/19/202415:02EDGAR2Form DEF 14A - Other definitive proxy statements
3/19/202416:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
3/19/202416:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/19/202406:09EDGAR2Form 8-K - Current report
11/20/202317:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/20/202317:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/06/202315:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/30/202315:15EDGAR2Form SC 13D/A - General statement of acquisition of..
10/27/202316:17EDGAR2Form 8-K - Current report
10/27/202315:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/26/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/26/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/26/202315:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/20/202320:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/17/202316:47GLOBETalaris Therapeutics Announces Stockholder Approval of..
10/10/202315:32EDGAR2Form 425 - Prospectuses and communications, business..
10/10/202315:30EDGAR2Form 8-K/A - Current report: [Amend]
10/06/202319:01DJNStocks to Watch: Shift Technologies, Talaris Therapeutics,..
10/06/202316:30EDGAR2Form 8-K - Current report
10/06/202316:27EDGAR2Form 425 - Prospectuses and communications, business..
10/06/202316:26EDGAR2Form 8-K - Current report
10/06/202316:09GLOBETalaris Therapeutics Declares Special Dividend In Connection..
10/04/202307:30GLOBENew York Blood Center Enterprises Acquires Commercial-Scale..
9/26/202307:24EDGAR2Form 425 - Prospectuses and communications, business..
9/26/202307:21EDGAR2Form 8-K - Current report
9/15/202305:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
9/13/202315:28EDGAR2Form S-4/A - Registration of securities, business..
9/13/202308:14EDGAR2Form 425 - Prospectuses and communications, business..
9/13/202308:13EDGAR2Form 8-K - Current report
9/11/202315:47EDGAR2Form S-4/A - Registration of securities, business..
8/28/202306:38EDGAR2Form 425 - Prospectuses and communications, business..
8/25/202315:34EDGAR2Form S-4/A - Registration of securities, business..
8/14/202306:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
6/22/202306:30GLOBETalaris Therapeutics and Tourmaline Bio Announce Merger..
5/26/202306:00GLOBETalaris Therapeutics Announces Leadership Transition

Your Recent History

Delayed Upgrade Clock